MOLECULAR PARTNERS AG MOLN 深 滬
等待開盤 09-20 09:30:00 美东时间
4.67
-0.170
-3.51%
華盛通- 最 高4.67
- 今 開4.46
- 成交量 2341股
- 最 低 4.46
- 昨 收 4.84
- 總市值 1.53亿
- 52周最高 12.70
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 3.32
- 委 比 -33.33%
- 總股本 3283.67万
- 歷史最高 32.04
- 量 比 1.12
- 振 幅 4.34%
- 歷史最低 3.32
- 每 手 1
- 風險率 1.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Molecular Partners reports 1H results
Molecular Partners press release (NASDAQ:MOLN): 1H GAAP EPS of -CHF0.80 Total revenues and other income of CHF4.3M, vs. CHF3.5M a year ago With CHF 159.1 million in cash and short-term time deposits a...
08-27 04:38
Molecular Partners Advances Therapeutic Platforms
Molecular Partners (MOLN) has released an update. Molecular Partners AG is adva...
08-27 04:27
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on M...
06-25 01:18
Molecular Partners’ New Therapy Shows AML Treatment Promise
Molecular Partners (MOLN) has released an update. Molecular Partners AG has unv...
06-14 23:17
Molecular Partners Unveils Promising Cancer Therapy
Molecular Partners (MOLN) has released an update. Molecular Partners AG, in col...
06-11 22:58
Market-Moving News for June 11th
MOLN: 11% | Molecular Partners shares are trading higher after the company announced the debut of their lead Raido-DARPin therapy candidate MP0712, targeting DLL3. OSG: 63% | QuantaSing Group Limited
06-11 20:29
Molecular Partners’ MP0317 Shows Promising Trial Results
Molecular Partners (MOLN) has released an update. Molecular Partners AG announc...
06-04 05:56
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading ...
06-03 17:35
Molecular Partners Ag Advances Clinical Pipeline
Molecular Partners Ag (MOLN) has released an update. Molecular Partners AG, a c...
05-17 05:27
Molecular Partners Announces Publication In Cancer Immunology Research Of Preclinical Data Supporting MP0533's Proposed Mechanism Of Action
Preclinical data of tetra-specific T cell engager MP0533 demonstrate preferential T cell mediated killing of AML cells, while sparing healthy cells Results highlight MP0533-mediated T-cell activation and tumor
04-29 23:01
